About Syndax Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Company type
- Public Company
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment.
Review our social media community guidelines below: https://syndax.com/social-media-community-guidelines/
Company locations
730 3rd Ave, Floor 9, New York, NY 10017, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Clinical Trials
- Biotechnology
- Pharmaceutical
On LinkedIn
- Followers
- 32,519
- People linked to this company
- 333
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
1,353,581,951 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.